Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · Real-Time Price · USD
3.080
+0.100 (3.36%)
Dec 5, 2025, 4:00 PM EST - Market closed
Sera Prognostics Market Cap
Sera Prognostics has a market cap or net worth of $118.87 million as of December 5, 2025. Its market cap has decreased by -42.11% in one year.
Market Cap
118.87M
Enterprise Value
18.93M
1-Year Change
-42.11%
Ranking
Category
Stock Price
$3.08
Market Cap Chart
Since the IPO on July 15, 2021, Sera Prognostics's market cap has decreased from $488.14M to $118.87M, a decrease of -75.65%. That is a compound annual growth rate of -27.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 115.01M | -58.16% |
| Dec 31, 2024 | 274.91M | 46.70% |
| Dec 29, 2023 | 187.39M | 379.49% |
| Dec 30, 2022 | 39.08M | -81.47% |
| Dec 31, 2021 | 210.90M | -56.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |